CD3-specific binding molecules
Summary
The USPTO granted Immunocore Limited Patent US12590152B2 covering CD3-specific binding molecules, specifically antibodies and fragments with improved properties. The patent contains 19 claims and names 8 inventors including Martina Canestraro and Stephen Harper. This is a routine patent grant establishing intellectual property rights without regulatory compliance obligations.
What changed
The USPTO issued Patent US12590152B2 to Immunocore Limited on March 31, 2026, covering CD3-specific binding molecules—antibodies and fragments with improved properties—based on Application No. 17427592 filed January 30, 2020. The patent is classified under CPC codes C07K 16/2809 and related peptide/antibody categories.
Patent holders receive enforceable exclusive rights to practice the claimed invention in the US. The public cannot practice the patented invention without authorization. This is a routine intellectual property action that does not impose compliance deadlines or regulatory requirements on third parties. Competitors developing CD3-binding therapeutics should review the claims for potential infringement concerns.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CD3-specific binding molecules
Grant US12590152B2 Kind: B2 Mar 31, 2026
Assignee
IMMUNOCORE LIMITED
Inventors
Martina Canestraro, Nele Dieckmann, Stephen Harper, Peter Benedict Kirk, Rachel Mulvaney, Ronan O'Dwyer, Ian Butler Robertson
Abstract
The present invention relates to specific binding molecules which bind to CD3, particularly antibodies and fragments thereof, with improved properties.
CPC Classifications
C07K 16/2809 C07K 2317/24 C07K 2317/31 C07K 2317/565 C07K 2317/567 C07K 2317/622 C07K 2317/73 C07K 2317/92 C07K 2319/00 C07K 14/7051 C07K 16/30 C07K 2317/70 A61K 2039/505
Filing Date
2020-01-30
Application No.
17427592
Claims
19
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.